eukaryotic translation initiation factor 2B subunit beta
Senast uppdaterad 18 aug 2020
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Den EIF2B2 gene provides instructions for making one of five parts of a protein called eIF2B, specifically the beta subunit of this protein. The eIF2B protein helps regulate overall protein production (synthesis) in the cell by interacting with another protein, eIF2. The eIF2 protein is called an initiation factor because it is involved in starting (initiating) protein synthesis.
Videoval för GenesVideobibliotek
Normal function
Den EIF2B2 gene provides instructions for making one of five parts of a protein called eIF2B, specifically the beta subunit of this protein. The eIF2B protein helps regulate overall protein production (synthesis) in the cell by interacting with another protein, eIF2. The eIF2 protein is called an initiation factor because it is involved in starting (initiating) protein synthesis.
Under some conditions, eIF2B increases protein synthesis by helping to recycle molecules called GTP, which carry energy to the initiation factor. Under other conditions, it slows protein synthesis by binding tightly to the initiation factor, which converts the eIF2B protein into an inactive form and prevents recycling of GTP.
Proper regulation of protein synthesis is vital for ensuring that the correct levels of protein are available for the cell to cope with changing conditions. For example, cells must synthesize protein much faster if they are multiplying than if they are in a resting state.
Conditions referring to this gene or chromosome
Other names
EI2BB_HUMAN
EIF-2Bbeta
EIF2B
eukaryotic translation initiation factor 2B, subunit 2 (beta, 39kD)
eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa
Related patient information and medicines

Patient information leaflet
Fakta om bröstcancer och riskfaktorer
What are the risk factors for breast cancer. Dr Sarah Jarvis MBE Although bröstcancer can develop for no apparent reason, there are certain risk factors which increase the chance that breast cancer will develop. /health/breast-cancer-leaflet Most cases of breast cancer occur by chance. However, breast cancer does occur more.

Patient information leaflet
Kan jag ta Royal sun och Shiitake tillsammans?
Both Royal Sun (Agaricus blazei) and Shiitake (Lentinula edodes) mushrooms contain höga nivåer av beta-glucans, which are substances that stimulate the immune system. Taking them together may cause your immune system to become overactive. Both mushrooms can lower blood sugar levels and thin the blood. Taking them together might increase the risk.

Patient information leaflet
Kan jag ta Shiitake och Turkisk svans tillsammans?
There are no known harmful interactions between shiitake and turkey tail mushrooms. Both are medicinal fungi that are often taken together to support the immune system. Why this happens Both mushrooms contain bioactive compounds called beta-glucans. These work in a similar way to support immune function without interfering with how the body.

Patient information leaflet
Kan jag ta Alogliptin och Bisoprolol tillsammans?
It can also slightly increase the risk of your blood sugar dropping too low. Why this happens Bisoprolol is a beta-blocker. These medicines can mask the physical symptoms of low blood sugar, such as a fast heartbeat or tremors. Using other medicines Taking multiple ... Our Medicines Interaction Checker helps you check whether your prescriptions,.

Patient information leaflet
Thalassemi
What is thalassaemia. Thalassemi is an inherited (genetic) condition affecting the blood. There are different types of thalassaemia. What causes thalassaemia. The cause is an inherited (genetic) change, involving the genes which tell the body how to make an important chemical called haemoglobin. Haemoglobin is the chemical which carries oxygen.

Patient information leaflet
Kan jag ta Apixaban och Bisoprolol tillsammans?
They work in different ways and do not interfere with how the body pr... Why this happens Apixaban is an anticoagulant (blood thinner) that works by blocking a clotting factor called Factor Xa. Bisoprolol is a beta-blocker that slows the heart rate and lowers blood pressure. They are processed by different pathways in the liver and kidneys, and.
Vidare läsning och referenser
- eukaryotic translation initiation factor 2B subunit beta; MedlinePlus, National Library of Medicine.
- Dietrich J, Lacagnina M, Gass D, Richfield E, Mayer-Proschel M, Noble M, Torres C, Proschel C. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy. Nat Med. 2005 Mar;11(3):277-83. doi: 10.1038/nm1195. Epub 2005 Feb 20.
- Eurekah Bioscience: Mechanism of Translation Initiation in Eukaryotes
- Fogli A, Boespflug-Tanguy O. The large spectrum of eIF2B-related diseases. Biochem Soc Trans. 2006 Feb;34(Pt 1):22-9. doi: 10.1042/BST20060022.
- Fogli A, Schiffmann R, Hugendubler L, Combes P, Bertini E, Rodriguez D, Kimball SR, Boespflug-Tanguy O. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients. Eur J Hum Genet. 2004 Jul;12(7):561-6. doi: 10.1038/sj.ejhg.5201189.
- Li W, Wang X, Van Der Knaap MS, Proud CG. Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways. Mol Cell Biol. 2004 Apr;24(8):3295-306. doi: 10.1128/MCB.24.8.3295-3306.2004.
- Molecular Biology of the Cell (fourth edition, 2002): The Phosphorylation of an Initiation Factor Globally Regulates Protein Synthesis
- Pavitt GD. eIF2B, a mediator of general and gene-specific translational control. Biochem Soc Trans. 2005 Dec;33(Pt 6):1487-92. doi: 10.1042/BST0331487.
- Pronk JC, van Kollenburg B, Scheper GC, van der Knaap MS. Vanishing white matter disease: a review with focus on its genetics. Ment Retard Dev Disabil Res Rev. 2006;12(2):123-8. doi: 10.1002/mrdd.20104.
- Scali O, Di Perri C, Federico A. The spectrum of mutations for the diagnosis of vanishing white matter disease. Neurol Sci. 2006 Sep;27(4):271-7. doi: 10.1007/s10072-006-0683-y.
- Scheper GC, Proud CG, van der Knaap MS. Defective translation initiation causes vanishing of cerebral white matter. Trends Mol Med. 2006 Apr;12(4):159-66. doi: 10.1016/j.molmed.2006.02.006. Epub 2006 Mar 20.
- van der Voorn JP, van Kollenburg B, Bertrand G, Van Haren K, Scheper GC, Powers JM, van der Knaap MS. The unfolded protein response in vanishing white matter disease. J Neuropathol Exp Neurol. 2005 Sep;64(9):770-5. doi: 10.1097/01.jnen.0000178446.41595.3a.
- van Kollenburg B, van Dijk J, Garbern J, Thomas AA, Scheper GC, Powers JM, van der Knaap MS. Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease. J Neuropathol Exp Neurol. 2006 Jul;65(7):707-15. doi: 10.1097/01.jnen.0000228201.27539.50.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
18 aug 2020 | Senaste versionen
1 Oct 2007 | Ursprungligen publicerad
Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.

